Wart treatment with anthralin.

Abstract

In order to investigate the efficacy of anthralin ( Anthraderm ) in the treatment of warts a randomized controlled trial was carried out in 72 patients. During a two-month period of treatment 56% were cured in the group treated with anthralin 2% ( Anthraderm ), evaluated at follow-up 2-9 months after finishing treatment, compared with 26% in the group treated with the comparative drug ( Verucid ). Anthralin 2% ( Anthraderm ) was found to have a significantly better effect, especially in the group of patients with warts solely on the hands.

• Authors: H Flindt-Hansen, G Tikjøb, F Brandrup
• Journal: Acta dermato-venereologica (Acta Derm Venereol) Vol. 64 Issue 2 Pg. 177-9 ( 1984) ISSN: 0001-5555 [Print] Sweden
• PMID: 6203313 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Anthracenes
• Drug Combinations
• Lactates
• Organometallic Compounds
• Plant Extracts
• Salicylates
• lactic acid, salicylic acid drug combination
• Lactic Acid
• Copper
• Anthralin

Topics

• Adolescent
• Adult
• Anthracenes (therapeutic use)
• Anthralin (therapeutic use)
• Child
• Clinical Trials as Topic
• Copper (therapeutic use)
• Drug Combinations (therapeutic use)
• Humans
• Lactates (therapeutic use)
• Lactic Acid
• Middle Aged
• Organometallic Compounds
• Plant Extracts (therapeutic use)
• Random Allocation
• Salicylates (therapeutic use)
• Skin Diseases (drug therapy)
• Warts (drug therapy)